After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Coverage (9)

• Alaunos Therapeutics surges after Velaris acquisition and $350 million financing Quiver Quantitative · 7h ago
• TCRT Stock Rockets On Heavy Volume As Traders Pile In StocksToTrade · 7h ago
• Paragon Labs adds former Apogee executives to leadership team Investing.com · 7h ago
• 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Benzinga · 7h ago
• Paragon Labs adds former Apogee executives to leadership team By Investing.com Investing.com Canada · 7h ago
• Alaunos Acquires Velaris and Secures Major Financing TipRanks · 7h ago
• Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc. PR Newswire · 7h ago
• Biotech builder Paragon imports Apogee's top brass after AbbVie buyout Fierce Biotech · 7h ago
• After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine Endpoints News · 7h ago

Related trends